Moment of truth-adding carboplatin to neoadjuvant/adjuvant chemotherapy in triple negative breast cancer improves overall survival: An individual participant data and trial-level Meta-analysis

IMPORTANCE: Carboplatin increases the pathological complete remission (pCR) rate in triple negative breast cancer (TNBC) when added to neoadjuvant chemotherapy, however, evidence on its effect on survival outcomes is controversial. METHODS: The study was prospectively registered at PROSPERO (CRD4202...

Descripción completa

Detalles Bibliográficos
Autores principales: Pathak, Neha, Sharma, Aparna, Elavarasi, Arunmozhimaran, Sankar, Jeeva, Deo, S.V.S., Sharma, Daya N., Mathur, Sandeep, Kumar, Sudhir, Prasad, Chandra P., Kumar, Akash, Batra, Atul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9039877/
https://www.ncbi.nlm.nih.gov/pubmed/35462344
http://dx.doi.org/10.1016/j.breast.2022.04.006

Ejemplares similares

Ejemplares similares